Your browser doesn't support javascript.
loading
To Be or Not To Be…Toxic-Is RNA Association With TDP-43 Complexes Deleterious or Protective in Neurodegeneration?
Loganathan, Suvithanandhini; Lehmkuhl, Erik M; Eck, Randall J; Zarnescu, Daniela C.
Afiliación
  • Loganathan S; Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ, United States.
  • Lehmkuhl EM; Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ, United States.
  • Eck RJ; Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ, United States.
  • Zarnescu DC; Department of Neuroscience, University of Arizona, Tucson, AZ, United States.
Front Mol Biosci ; 6: 154, 2019.
Article en En | MEDLINE | ID: mdl-31998750
ABSTRACT
TAR DNA binding protein (TDP-43) is a nucleic acid binding protein associated with insoluble cytoplasmic aggregates in several neurodegenerative disorders, including 97% of the ALS cases. In healthy individuals, TDP-43 is primarily localized to the nucleus; it can shuttle between the nucleus and the cytoplasm, and is involved in several aspects of RNA processing including transcription, splicing, RNA stability, transport, localization, stress granule (SG) formation, and translation. Upon stress, TDP-43 aggregates in the cytoplasm and associates with several types of RNA and protein assemblies, resulting in nuclear depletion of TDP-43. Under conditions of prolonged stress, cytoplasmic TDP-43 undergoes liquid-liquid phase separation (LLPS) and becomes less mobile. Evidence exists to support a scenario in which insoluble TDP-43 complexes sequester RNA and/or proteins causing disturbances in both ribostasis and proteostasis, which in turn contribute to neurodegeneration. However, the relationship between RNA binding and TDP-43 toxicity remains unclear. Recent studies provide conflicting views on the role of RNA in TDP-43 toxicity, with some finding RNA as a toxic factor whereby RNA binding contributes to TDP-43 toxicity, while others find RNA to be a protective factor that inhibits TDP-43 aggregation. Here we review and discuss these recent reports, which ultimately highlight the importance of understanding the heterogeneity of TDP-43 assemblies and collectively point to solubilizing TDP-43 as a potential therapeutic strategy.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Mol Biosci Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Mol Biosci Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos